Microarray analysis revealed markedly differential miRNA expression profiles in cervical intraepithelial neoplasias and invasive squamous cell carcinoma

Future Oncology

Volumn 10, Issue 13, 2014, Pages 2023-2032

  Liang, Shuang ^a   Tian, Tian ^a   Liu, Xubin ^a   Shi, Huijuan ^a   Tang, Cuilan ^a   Yang, Shicong ^a   Wang, Liantang ^a   Chen, Shangwu ^a   Yu, Li ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasias; CIN; FFPE tissue; Formalin fixed, paraffin embedded tissue; Microarray; MicroRNAs; MiRNAs

Indexed keywords

MICRORNA;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE SQUAMOUS CELL CARCINOMA; MICROARRAY ANALYSIS; MICROARRAY KIT; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR INVASION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; REPRODUCIBILITY; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 84911020701     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/FON.14.38     Document Type: Article

References (36)

1. McCredie MR, Sharples KJ, Paul C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9(5), 425-434 (2008).
2. Wallin KL, Wiklund F, Angstrom T et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med. 341(22), 1633-1638 (1999).
3. Winer RL, Kiviat NB, Hughes JP et al. Development and duration of human papillomavirus lesions, after initial infection. J. Infect. Dis. 191(5), 731-738 (2005).
4. Zielinski GD, Snijders PJ, Rozendaal L et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br. J. Cancer 85(3), 398-404 (2001).
5. Lee JW, Choi CH, Choi JJ et al. Altered microRNA expression in cervical carcinomas. Clin. Cancer Res. 14(9), 2535-2542 (2008).
6. Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 67(13), 6031-6043 (2007).
7. Rao Q, Shen Q, Zhou H, Peng Y, Li J, Lin Z. Aberrant microRNA expression in human cervical carcinomas. Med. Oncol. 29(2), 1242-1248 (2011).
8. Wang X, Tang S, Le SY et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3(7), e2557 (2008).
9. Gocze K, Gombos K, Juhasz K et al. Unique microRNA expression profiles in cervical cancer. Anticancer Res. 33(6), 2561-2567 (2013).
10. Zhao S, Yao DS, Chen JY, Ding N. Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac. J. Cancer Prev. 14(4), 2289-2293 (2013).
11. Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L, Wang H. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn. Pathol. 8, 69 (2013).
12. Xu J, Li Y, Wang F et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32(8), 976-987 (2013).
13. Hu X, Schwarz JK, Lewis JS, Jr et al. A microRNA expression signature for cervical cancer prognosis. Cancer Res. 70(4), 1441-1448 (2010).
14. Liu S, Zhang P, Chen Z, Liu M, Li X, Tang H. MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett. 587(14), 2247-2253 (2013).
15. Qin W, Dong P, Ma C et al. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 31(36), 4067-4075 (2012).
16. Li B, Hu Y, Ye F, Li Y, Lv W, Xie X. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int. J. Gynecol. Cancer 20(4), 597-604 (2010).
17. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27(18), 2575-2582 (2008).
18. Au Yeung CL, Tsang TY, Yau PL, Kwok TT. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 30(21), 2401-2410 (2011).
19. Li Y, Wang F, Xu J et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J. Pathol. 224(4), 484-495 (2011).
20. Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA. MicroRNA expression variability in human cervical tissues. PLoS ONE 5(7), e11780 (2010).
21. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol. 12(2), 186-192 (1993).
22. miRBase: the microRNA database. www.mirbase.org
23. Liu A, Tetzlaff MT, Vanbelle P et al. MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int. J. Clin. Exp. Pathol. 2(6), 519-527 (2009).
24. Tetzlaff MT, Liu A, Xu X et al. Differential expression of miRNAs in papillary thyroid carcinoma compared with multinodular goiter using formalin fixed paraffin embedded tissues. Endocr. Pathol. 18(3), 163-173 (2007).
25. Glud M, Klausen M, Gniadecki R et al. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. J. Invest. Dermatol. 129(5), 1219-1224 (2009).
26. Zhang X, Chen J, Radcliffe T, Lebrun DP, Tron VA, Feilotter H. An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J. Mol. Diagn. 10(6), 513-519 (2008).
27. Hui AB, Shi W, Boutros PC et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab. Invest. 89(5), 597-606 (2009).
28. Zhao Y, Deng C, Wang J et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res. Treat. 127(1), 69-80 (2011).
29. Kheirelseid EA, Miller N, Chang KH et al. miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. Int. J. Colorectal Dis. 28(2), 247-260 (2013).
30. Li X, Lu Y, Chen Y, Lu W, Xie X. MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples. BMC Cancer 13, 216 (2013).
31. Lebanony D, Benjamin H, Gilad S et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J. Clin. Oncol. 27(12), 2030-2037 (2009).
32. Weng L, Wu X, Gao H et al. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J. Pathol. 222(1), 41-51 (2010).
33. Wilting SM, Snijders PJ, Verlaat W et al. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 32(1), 106-116 (2013).
34. Cheung TH, Man KN, Yu MY et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11(15), 2876-2884 (2012).
35. Yao T, Lin Z. miR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim. Biophys. Acta 1822(2), 248-260 (2012).
36. Deftereos G, Corrie SR, Feng Q et al. Expression of miR-21 and miR-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS ONE 6(12), e28423 (2011).